Biotech

All Articles

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on failed epilepsy medicine, proclaims FDA manage

.We currently recognize that Takeda is actually hoping to discover a course to the FDA for epilepsy ...

VBI Injections declare personal bankruptcy, looks for resource sale

.Immunology biotech VBI Vaccines is actually turning alarmingly near to the defining moment, with pr...

Celldex anti-cKIT antibody minimize hives in another period 2 research study

.It is actually hard to muscle mass in on a space as competitive as immunology, however Celldex Ther...

Boehringer offers up to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapies as well as a preclinical invu...

Ventyx's last hope for inflamed med sides in Crohn's failure

.Ventyx Biosciences' Crohn's disease medicine did not help individuals achieve remission in a phase ...

Cognition's stage 2 radiate data stain Alzheimer's prospect

.Cognition Therapies' stage 2 sparkle test has actually taken several of the gloss off the Alzheimer...

BMS axes bispecific months after filing to work phase 3 trial

.Bristol Myers Squibb has actually had a whiplash change of heart on its BCMA bispecific T-cell enga...

Charles Baum manages Terremoto as CEO

.Charles Baum, M.D., Ph.D., who supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myers...

Asarina to shut after attempts to partner Tourette's medicine neglect

.After connecting to much more than 200 firms to partner a Tourette syndrome treatment that presente...